Posted in Prostate Cancer News on Jun 28th, 2008
A Reuters news story (originated by the journal Urology) explains how obesity makes it harder for the PSA test to do what it’s supposed to do … detect prostate cancer. The prostate-specific antigen test (or PSA for short) is the common method used to detect prostate cancer in men.
Prostate-specific antigen (PSA) is a protein produced […]
Read Full Post »
Posted in Prostate Cancer News on Nov 17th, 2007
Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
Clinical Trial Aimed to Supplement Current Research Findings on the Treatment of Localized Prostate Cancer
TORONTO, Nov. 14 /PRNewswire/ — A Canadian study on High Intensity
Focused Ultrasound therapy with the Sonablate(R) 500 - a Health Canada
approved treatment for localized prostate cancer - is underway at Can-Am
HIFU. Through funding […]
Read Full Post »
Posted in Prostate Cancer News on Nov 17th, 2007
SARASOTA, Fla., Nov. 5 /PRNewswire/ — JM, a 71 year old business
executive from Tennessee, had a negative biopsy using gray scale ultrasound
despite a PSA of 7.1. The following year, the PSA rose to 11.5 prompting a
second biopsy that was negative despite adding Color Flow Doppler
Ultrasound.
At this point, the patient and all doctors in attendance were
frustrated […]
Read Full Post »
Posted in Prostate Cancer News on Nov 17th, 2007
Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
S.T.A.R Program Brings Together Researchers from North America’s
Leading Prostate Cancer Centers
WASHINGTON, Nov. 15 /PRNewswire/ — Safeway Inc. and the Prostate
Cancer Foundation today announced they will collectively donate $6 million
to fund the S.T.A.R. Program (for Special Team Amplification of Research),
an innovative research initiative […]
Read Full Post »